Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19

(Reuters) – Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on Wednesday it had raised $105 million in funds. AbCellera has been working with pharmaceutical firm Eli Lilly and Co (LLY.N) which is developing a coronavirus drug based on antibodies from patients that have recovered

» Read more

Solo lunches and masks: Chinese returning to work grapple with coronavirus

BEIJING/SHANGHAI (Reuters) – Chinese government employee Jin Yang returned to work in Beijing this week to find his usual workplace rules upended as China battles a coronavirus epidemic. His office has banned the practice of eating lunch in its canteen with colleagues, in favor of boxed meals, packaged in house and eaten at desks, he said. “It’s anything but normal,”

» Read more